Planning Strategies’s Eledon Pharmaceuticals ELDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$458 Hold
181
– – ﹤0.01% 948
2026
Q2
$713 Buy
+181
New +$658 ﹤0.01% 800

Other funds holding ELDN

Planning Strategies's ELDN Position: Q3 2026 in Review

Planning Strategies held its Eledon Pharmaceuticals (ELDN) position steady in Q3 2026 at 181 shares worth $458. The position accounts for ﹤0.01% of the portfolio, ranked #948.

Planning Strategies first reported a position in ELDN in Q2 2026 and has held it in 2 quarters since. The position peaked at $713 in Q2 2026. 127 funds tracked by Wall St. Rank hold ELDN as of Q3 2026.

  • Planning Strategies held 181 shares of Eledon Pharmaceuticals worth $458 as of Q3 2026.
  • Planning Strategies left its Eledon Pharmaceuticals share count unchanged in Q3 2026.
  • Eledon Pharmaceuticals made up ﹤0.01% of Planning Strategies's portfolio in Q3 2026, its #948 holding.
  • Planning Strategies first reported a position in Eledon Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • Planning Strategies's Eledon Pharmaceuticals position peaked at $713 in Q2 2026.
  • 127 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q3 2026.

Based on Planning Strategies's 13F filing for Q3 2026, filed 2 Oct 2026.